SCHEMBL1853570

SCHEMBL1853570

O=c1sc2cc(O)ccc2n1C=Cc1ccc(F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.40
ESR1 P03372 4/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
HTR6 P50406 2/20 0.38
SHMT2 P34897 1/20 0.37
CTSL P07711 1/20 0.36
TNKS O95271 1/20 0.36
PARP1 P09874 1/20 0.36
PARP15 Q460N3 1/20 0.36
PARP14 Q460N5 1/20 0.36
PARP10 Q53GL7 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
PARP11 Q9NR21 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
PARP4 Q9UKK3 1/20 0.36
PARP3 Q9Y6F1 1/20 0.36
SLC5A1 P13866 1/20 0.36
SLC5A2 P31639 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1853568 1.00 PTGS1 (0.40) PTGS1ESR1MMP1MMP2MMP9
SCHEMBL1851409 0.86 MEN1 (0.38) ESR1MMP1MMP2MMP9TNKS
SCHEMBL1851407 0.86 MEN1 (0.38) ESR1MMP1MMP2MMP9TNKS
SCHEMBL1852734 0.86 PTGS1 (0.43) PTGS1ESR1MMP1MMP2MMP9
SCHEMBL1852736 0.86 PTGS1 (0.43) PTGS1ESR1MMP1MMP2MMP9
SCHEMBL3303698 0.78 KMT2A (0.47) MMP1MMP2MMP9
SCHEMBL3303703 0.78 KMT2A (0.47) MMP1MMP2MMP9
SCHEMBL14864458 0.69 HTR6 (0.50) ESR1HTR6MAOAMAOBADORA2A
SCHEMBL4615636 0.69 HTR1A (0.45) TNKSPARP1PARP15PARP14PARP10
SCHEMBL13394645 0.68 L3MBTL1 (0.45) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB PTGS1 2384/4885ESR1 3483/4885MMP1 2143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.